Markets › Stocks › ASPIRA
AS

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRABSE: 540788Healthcare
Download Research Report7-page PDF
₹125.00
▲ +0.00%
NSE · auto-updates while market open
Mkt Cap
₹129 Cr
P / E
-
P / B
10.5
ROE
0.1%
52W High
₹135.88
52W Low
₹49.00
Key Metrics
Market Cap
₹129 Cr
P / E
-
P / B
10.52
EV / EBITDA
87.71
ROCE
3.3%
ROE
0.1%
Debt / Equity
0.11
Book Value
₹11.88
EPS
₹0.05
Div Yield
0.0%
Face Value
-
Promoter Holding
18.4%
Revenue · ₹ Cr
8
FY20
15
FY21
20
FY22
14
FY23
13
FY24
22
FY25
25
FY26
Net Profit · ₹ Cr
1
4
2
0
-4
0
-3
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹1.6
₹4.3
₹2.6
₹2.0
₹0.1
₹-4.6
₹-0.1
FY20FY21FY22FY23FY24FY25FY26
Q2 2025 snapshot
Sales
₹5 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.41
Scorecard · 7 axes
Quality
Avg
48/100
Valuation
-
Growth
Weak
+3.2%
Profitability
Bad
1.7%
Performance
Strong
+133.6%
Entry Point
Weak
92%
Red Flags
Strong
0 flags
Shareholding Pattern
18.4%Promoter
Promoter18.4%
Public81.6%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue5.55.915.368.235.256.66
Net Profit0.3060.6810.4221.835-1.561-0.689
NPM %5.6%11.5%7.9%22.3%-29.7%-10.3%
AlertPre-trade